Produkten har lagts i din varukorg Visa varukorgenTill kassan
Din webbläsare stöds ej. För bästa upplevelsen rekommenderas en nyare version eller en annan webbläsare.
För att ge dig bättre service använder vi cookies. Genom att fortsätta på sidan godkänner du vår användning av cookies.

PD-1 0,1 mL

BC-ACI3137AK
Produktfråga

Vad vill du veta om PD-1 0,1 mL?

Skicka

Beskrivning

Programmed death 1 (PD-1) is a cell surface co-receptor in the CD28/CTLA-4 T cell family and functions as a down regulator of the immune system through a dual mechanism of inhibition (1). PD-1 is expressed on the cell surface of activated T- and B-cells. Anti-tumor immunity may be controlled by the PD-1/PD-L1 signaling pathway. PD-L1, one of the ligands associated with PD-1, provides immunity for tumor cells by inducing apoptosis of activated T cells or by inhibiting cytotoxic T cells (1,2). Therapies that target the
PD-1 receptor have shown unprecedented results with high levels of clinical response in patients with various cancer types (3). The presence of PD-1 positive tumor-infiltrating lymphocytes (TIL) has been associated with poor prognosis in human breast cancers and may be useful in antibody therapy targeting the PD-1/PD-L1 signaling pathway (1). Treatments targeting PD-1 and its ligand, PD-L1, have also shown encouraging results in non-small-cell lung cancer, renal cell carcinoma and melanoma (4-6).
 
INTENDED USE:        IVD
FORMAT :                 Concentrate, Predilute
VOLUME:                 
0.1 ml, 1.0 ml, 6.0 ml
SOURCE:                  Mouse Monoclonal
CLONE:                     NAT105
ISOTYPE:                  IgG1/kappa
ANTIGEN:                  PD-1
LOCALIZATION:         Cytoplasmic
POSITIVE CONTROL: Tonsil
Läs mer ...Stäng